Dr. Ding Wang
Claim this profileHenry Ford Hospital
Expert in Lung Cancer
Studies Cancer
47 reported clinical trials
104 drugs studied
About Ding Wang
Education:
- Holds an MD (Doctor of Medicine).
- Earned a PhD (Doctor of Philosophy).
Experience:
- Serves as the Medical Director of the Clinical Trials Office at Henry Ford Health System.
- Principal Investigator for over 150 clinical trials.
- Manages a team of clinical research professionals and ensures compliance with regulatory standards.
- Provides administrative and financial oversight for approximately 170 clinical research projects.
- Facilitates staff certification in Good Clinical Practice and Human Subject's Protection.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Ding Wang is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Ding Wang
Clinical Trial Related6 years of experience running clinical trials · Led 47 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Ding Wang has experience with
- Nivolumab
- Pembrolizumab
- Cisplatin
- Carboplatin
- Gemcitabine Hydrochloride
- Ipilimumab
Breakdown of trials Ding Wang has run
Lung Cancer
Cancer
Pancreatic Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ding Wang specialize in?
Ding Wang focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ding Wang currently recruiting for clinical trials?
Yes, Ding Wang is currently recruiting for 15 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Ding Wang has studied deeply?
Yes, Ding Wang has studied treatments such as Nivolumab, Pembrolizumab, Cisplatin.
What is the best way to schedule an appointment with Ding Wang?
Apply for one of the trials that Ding Wang is conducting.
What is the office address of Ding Wang?
The office of Ding Wang is located at: Henry Ford Hospital, Detroit, Michigan 48202 United States. This is the address for their practice at the Henry Ford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.